Patents by Inventor Hee Sook Oh

Hee Sook Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTAL FORM OF ACID ADDITION SALT OF FUROPYRIMIDINE COMPOUND
    Publication number: 20220177483
    Abstract: Provided are crystalline forms of acid addition salts of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)furo[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide, and a pharmaceutical composition including the same. The crystalline forms may be easily used in preparing the pharmaceutical composition including the same as an active ingredient.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 9, 2022
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Hee Sook OH, Jae Hyuk JUNG, Ji Young JEON, Sun Young JANG, Tae Hee HA
  • Crystalline forms of hydrochloride salts of thienopyrimidine compound
    Patent number: 11008333
    Abstract: A crystalline form of an alkyl benzene sulfonyl urea compound that is useful as an oral antidiabetics is disclosed. Specifically, the compound is a hydrochloride salt of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide of the following formula I.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: May 18, 2021
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Jong Ouk Baek, Ji Young Jeon, Hee Sook Oh, Hee Cheol Kim, Sun Young Jang, Tae Hee Ha
  • CRYSTALLINE FORMS OF HYDROCHLORIDE SALTS OF THIENOPYRIMIDINE COMPOUND
    Publication number: 20200270268
    Abstract: The present invention relates to a crystalline form of a hydrochloride salt of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide, and a pharmaceutical composition containing the same. The crystalline form of the hydrochloride salt of the compound can be easily used for preparing a pharmaceutical composition containing the same as an active ingredient.
    Type: Application
    Filed: December 30, 2016
    Publication date: August 27, 2020
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Jong Ouk BAEK, Ji Young JEON, Hee Sook OH, Hee Cheol KIM, Sun Young JANG, Tae Hee HA
  • Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
    Patent number: 8586752
    Abstract: Disclosed are a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: November 19, 2013
    Assignee: Hanmi Science Co., Ltd
    Inventors: Tae Hee Ha, Hee Sook Oh, Won Jeoung Kim, Chang Hee Park, Eun Young Kim, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee
  • CRYSTALLINE S-OMEPRAZOLE STRONTIUM HYDRATE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    Publication number: 20130303772
    Abstract: Disclosed are a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, thermostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Application
    Filed: July 16, 2013
    Publication date: November 14, 2013
    Inventors: Tae Hee HA, Hee Sook OH, Won Jeoung KIM, Chang Hee PARK, Eun Young KIM, Young Hoon KIM, Kwee Hyun SUH, Gwan Sun LEE
  • Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
    Patent number: 8513426
    Abstract: Disclosed are a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: August 20, 2013
    Assignee: Hanmi Science Co., Ltd
    Inventors: Tae Hee Ha, Hee Sook Oh, Won Jeoung Kim, Chang Hee Park, Eun Young Kim, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee
  • Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
    Patent number: 8106076
    Abstract: This invention provides a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: January 31, 2012
    Assignee: Hanmi Holdings Co., Ltd.
    Inventors: Tae Hee Ha, Hee Sook Oh, Won Jeoung Kim, Chang Hee Park, Eun Young Kim, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee
  • CRYSTALLINE S-OMEPRAZOLE STRONTIUM HYDRATE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    Publication number: 20110046383
    Abstract: Disclosed are a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Application
    Filed: October 28, 2010
    Publication date: February 24, 2011
    Applicant: Hanmi Pham. Co., Ltd.
    Inventors: Tae Hee HA, Hee Sook Oh, Won Jeoung Kim, Chang Hee Park, Eun Young Kim, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee
  • Method of preparing esomeprazole and salts thereof
    Patent number: 7888511
    Abstract: Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(?)-binol, a weak base and the racemic form of omeprazole in a mixture of a water-compatible organic solvent and water at a high temperature, cooling the mixed solution to crystallize the inclusion complex of esomeprazole and (S)-(?)-binol, and removing the (S)-(?)-binol moiety from the crystallized inclusion complex.
    Type: Grant
    Filed: July 11, 2006
    Date of Patent: February 15, 2011
    Assignee: Hanmi Holdings Co., Ltd.
    Inventors: Tae Hee Ha, Won Jeong Kim, Hee Sook Oh, Chang Hee Park, Jae Chul Lee, Han Kyong Kim, Kwee-Hyun Suh
  • NOVEL CRYSTALLINE BEPOTASTINE METAL SALT HYDRATE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20100137367
    Abstract: The present invention discloses a non-hygroscopic crystalline bepotastine metal salt hydrate, a method for preparing same, and a pharmaceutical composition comprising same for treating or preventing a histamine-mediated disease or an allergic disease.
    Type: Application
    Filed: April 4, 2008
    Publication date: June 3, 2010
    Applicant: Hanmi Pharm. Co., Ltd.
    Inventors: Tae Hee Ha, Chang Hee Park, Won Jeoung Kim, Hee Sook Oh, Seung Hwan Cho, Cheol Kyung Kim, Kwee Hyun Suh, Gwan Sun Lee
  • Crystalline S-Omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
    Publication number: 20090258908
    Abstract: This invention provides a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Application
    Filed: April 17, 2009
    Publication date: October 15, 2009
    Applicant: Hanmi Pharm. Co., Ltd.
    Inventors: Tae Hee HA, Hee Sook OH, Won Jeoung KIM, Chang Hee PARK, Eun Young KIM, Young Hoon KIM, Kwee Hyun SUH, Gwan Sun LEE
  • Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
    Patent number: 7576219
    Abstract: This invention provides a crystalline S-omeprazole strontium hydrate for the prevention or treatment of gastric acid-related diseases, which has high optical purity, theremostability, solubility and nonhygroscopicity, a method for preparing same, and a pharmaceutical composition containing same.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: August 18, 2009
    Assignee: Hanmi Pharm. Co., Ltd
    Inventors: Tae Hee Ha, Hee Sook Oh, Won Jeoung Kim, Chang Hee Park, Eun Young Kim, Young Hoon Kim, Kwee Hyun Suh, Gwan Sun Lee
  • Method of Preparing Esomeprazole and Salts Thereof
    Publication number: 20080194828
    Abstract: Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(?)-binol, a weak base and the racemic form of omeprazole in a mixture of a water-compatible organic solvent and water at a high temperature, cooling the mixed solution to crystallize the inclusion complex of esomeprazole and (S)-(?)-binol, and removing the (S)-(?)-binol moiety from the crystallized inclusion complex.
    Type: Application
    Filed: July 11, 2006
    Publication date: August 14, 2008
    Inventors: Tae Hee Ha, Won Jeong Kim, Hee Sook Oh, Chang Hee Park, Jae Chul Lee, Han Kyong Kim, Kwee-Hyun Suh